Skip to content

Study on the eficacy of liposomal bupivacaine for postoperative pain after total knee arthroplasty: A randomized controlled trial

Study on the efficacy of liposomal bupivacaine for postoperative pain after total knee arthroplasty: A randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107423
Enrollment
Unknown
Registered
2025-08-11
Start date
2025-08-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after knee arthroplasty

Interventions

Experimental group (Group C):The formula is bupivacaine liposome 266mg (20ml)+0.9% physiological saline (10ml), forming a 30ml mixture. Ultrasound guided adductor block is performed before anesthesia.
Control group (group D):The control group was given 30ml of 0.33% ropivacaine solution and underwent ultrasound-guided myotube block before anesthesia.

Sponsors

Puyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 18-80 years, with ASA classification of I-III, BMI of 18-28kg/m^2, planning to undergo elective unilateral total knee arthroplasty for the first time, with no history of chronic opioid use (using opioids daily or almost daily for more than 3 months) before surgery

Exclusion criteria

Exclusion criteria: Refusal to participate in this study; history of previous neurological diseases; severe preoperative heart, lung, liver, kidney, and immune function diseases; preoperative schizophrenia, epilepsy, Parkinson's disease, and myasthenia gravis; preoperative inability to communicate due to coma, severe dementia, or language barrier; severe liver dysfunction (Child-Pugh C grade), renal dysfunction (undergoing dialysis before surgery), or expected survival of <= 24 hours; allergy to local anesthetic drugs

Design outcomes

Primary

MeasureTime frame
The results of the 10 meter walk experiment 24 hours after the injection of the experimental drug;

Secondary

MeasureTime frame
The results of the 10 meter walking experiment at 48h and 72h after the injection of the experimental drug;Record the NRS scores of patients' pain during static and dynamic periods at 24h, 48h, and 72h after the injection of the experimental drug;

Countries

China

Contacts

Public ContactCunli Cao

Puyang People's Hospital

ccl2327@163.com+86 186 3939 9135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026